Description
Trifluridine and tipiracil is an oral chemotherapy combination used to treat metastatic colorectal and gastric cancers. Trifluridine disrupts cancer cell DNA, while tipiracil enhances its efficacy by preventing degradation. This therapy extends survival in patients unresponsive to standard treatments, offering renewed clinical hope.